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any proteins retained within the endo/sarcoplasmic
 
reticulum (ER/SR) lumen express the COOH-
terminal tetrapeptide KDEL, by which they con-
tinuously recycle from the Golgi complex; however, others
do not express the KDEL retrieval signal. Among the latter
 
is calsequestrin (CSQ), the major Ca
 
2
 
 
 
-binding protein
condensed within both the terminal cisternae of striated
 
muscle SR and the ER vacuolar domains of some neurons
 
and smooth muscles.
 
 
 
To reveal the mechanisms of con-
densation and establish whether it also accounts for ER/SR
retention of CSQ, we generated a variety of constructs:
chimeras with another similar protein, calreticulin (CRT);
mutants truncated of COOH- or NH
 
2
 
-terminal domains;
and other mutants deleted or point mutated at strategic
M
 
sites. By transfection in L6 myoblasts and HeLa cells we
show here that CSQ condensation in ER-derived vacuoles
requires two amino acid sequences, one at the NH
 
2
 
 termi-
nus, the other near the COOH terminus. Experiments with
a green ﬂuorescent protein GFP/CSQ chimera demonstrate
that the CSQ-rich vacuoles are long-lived organelles, unaf-
fected by Ca
 
2
 
 
 
 depletion, whose almost complete lack of
movement may depend on a direct interaction with the ER.
CSQ retention within the ER can be dissociated from con-
densation, the ﬁrst identiﬁed process by which ER luminal
proteins assume a heterogeneous distribution. A model is
proposed to explain this new process, that might also be
valid for other luminal proteins.
 
Introduction
 
The lumen of the ER is now recognized as a key compart-
ment of the cell in which multiple functions are carried out
and/or regulated by resident, nonmembrane proteins (for re-
views see Meldolesi and Pozzan, 1998; Corbett and Micha-
lak, 2000; Molinari and Helenius, 2000). The majority of
the ER lumenal proteins terminate with the KDEL amino
acid sequence (Pelham et al., 1988). Binding of this signal to
specific KDEL membrane receptors at the level of the Golgi
complex (Lewis and Pelham, 1990), followed by vesicle recy-
cling, provides a dynamic retrieval mechanism for accumula-
tion of ER luminal proteins. In addition, KDEL-dependent
retrieval results in intermixing of the recycling-competent
proteins, and therefore may contribute to their diffuse distri-
bution throughout the entire ER system (for reviews see
Lewis and Pelham, 1996; Meldolesi and Pozzan, 1998).
However, several proteins that reside in the ER lumen do
not terminate with the KDEL retrieval signal. The best
known example of a luminal protein without a KDEL signal
 
is calsequestrin (CSQ),* a low affinity–high capacity Ca
 
2
 
 
 
-
binding protein (MacLennan and Wong, 1971). CSQ is
found in dense, highly concentrated (up to 1–2 mmol/liter)
filamentous matrices segregated within the terminal cister-
nae of the sarcoplasmic reticulum (SR). The SR is the ER
subcompartment highly developed in striated muscle fibers,
and characterized by a precisely defined architecture because
of its intimate interaction with the plasmalemma T-tubule
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membrane. In contrast, the SR longitudinal cisternal net-
work distributed around muscle myofibrils is almost com-
pletely devoid of CSQ (Cala et al., 1990; Jorgensen et al.,
1993; Franzini-Armstrong and Jorgensen, 1994; Meldolesi
and Pozzan, 1998). The unique distribution of CSQ is of
key physiological importance. Due to their proximity to ry-
anodine receptors (the SR Ca
 
2
 
 
 
 channels), the condensed
CSQ matrices contribute to the regulation of Ca
 
2
 
 
 
 fluxes
(Ohkura et al., 1998; Szegedi et al., 1999) and provide the
pool of Ca
 
2
 
 
 
 necessary to trigger and sustain muscle contrac-
tion (Franzini-Armstrong and Jorgensen, 1994).
Condensation of CSQ to yield dense organelle cores does
not take place in the terminal cisternae only, but also exists
within the discrete corbular vacuoles of the heart SR, and
within ER cisternae and vacuoles in some smooth muscle
and neurons (Wuytack et al., 1987; Villa et al., 1991, 1993;
Volpe et al., 1991). Moreover, the same process of conden-
sation occurs in other cells (L6 myoblasts, PC12 pheochro-
mocytoma, and HeLa epithelial cells) when transfected with
a CSQ expression vector (Papazafiri et al., 1994; Raichman
et al., 1995; Gatti et al., 1997). This indicates that intralu-
minal condensation of CSQ is a physiological property that
exists in any cell in which the protein is expressed. The con-
densed organelle cores, which also contain trace amounts of
other ER proteins, remain in equilibrium with a soluble
pool of protein (Gatti et al., 1997). The molecular mecha-
nisms responsible for condensation and specific redistribu-
tion of CSQ in the lumen of ER/SR are not known.
Here we demonstrate that condensation of CSQ is due to
oligomerization. As a result the protein, retained within the
ER/SR lumen by an independent mechanism, does assume
its typical heterogeneous distribution. We also identify two
amino acid sequences that are essential for condensation of
the protein, one at the NH
 
2
 
 terminus (residues 1–15, hereaf-
 
ter referred to as site A) and one near the COOH terminus
(residues 337–357, hereafter referred to as site B) of CSQ.
 
Results
 
CSQ/CRT tail exchange
 
To investigate the mechanism of CSQ condensation within
the ER/SR lumen, expression vectors pcDNA CSQ/CRT
and pcDNA CRT/CSQ were created. These vectors encode
chimeras containing the bulk of the NH
 
2
 
-terminal region of
either CSQ or calreticulin (CRT) (an ER luminal Ca
 
2
 
 
 
-
binding chaperone) in frame with the COOH-terminal re-
gion of the other (Fig. 1 A). Although distinct for KDEL ex-
pression (in CRT only) and luminal distribution (condensed
and diffuse, respectively), CSQ and CRT share a general
structural similarity, especially at their COOH-terminal tail.
Thus, the general organization of the two chimeras was ex-
pected to largely maintain that of native proteins.
In each experiment, preparations of L6 myoblasts not ex-
pressing endogenous CSQ were cotransfected with two ex-
pression vectors, one encoding a specific chimera (Fig. 1 A),
and the other encoding influenza hemagglutinin (HA)-
tagged, full-length CSQ or CRT. Similar experiments were
carried out with HeLa cells (unpublished data). As expected,
we found by immunocytochemistry with anti-HA antibodies
that the distribution of HA-CSQ was punctate (Fig. 1 B
 
 
 
).
Moreover, the distribution was unchanged when, instead of
the full-length CSQ, we used the protein with a KDEL sig-
nal attached at the COOH terminus (unpublished data).
Thus, the condensed state of CSQ does not depend on its
KDEL-free COOH terminus. In contrast to CSQ, the dis-
tribution of HA-tagged CRT was diffuse (Fig. 1, C
 
 
 
 and D
 
 
 
;
Gatti et al., 1997). Ultrastructural immunocytochemistry of
the HA-tagged CSQ- and CRT-transfected cells confirmed
Figure 1. Generation and expression of CRT 
and CSQ chimeras in L6 myoblasts. (A) 
Graphic representation of the two chimeras, 
CSQ/CRT and CRT/CSQ, obtained by the swap-
ping of the CSQ (residues 325–391) and CRT 
(residues 318–401) tails. (B, B , C, C , D, and 
D ) Immunofluorescence with anti-CSQ (B–D) 
and anti-HA (B –D ) Abs in L6 cells cotrans-
fected with the CSQ/CRT chimera and HA-CSQ 
(B and B ), the same chimera with HA-CRT 
(C and C ), and the CRT/CSQ chimera with HA-
CRT (D and D ). (E and F) Ultrathin cryosec-
tions of L6 cells immunolabeled with anti-CRT 
(E) and anti-CSQ (F) Abs showing positive stain-
ing of ER cisternae and vacuoles, respectively. 
Bar (for E and F): 0.25  m. 
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that the CSQ puncta are membrane-delimited vacuoles filled
with the Ca
 
2
 
 
 
-binding protein (Fig. 1 F), whereas the diffuse
pattern of CRT is due to its distribution throughout the ER
cisternae (Fig. 1 E; Gatti et al., 1997). CSQ/CRT (Fig. 1, B
and C) and CRT/CSQ (Fig. 1 D) showed a diffuse but not
punctate distribution, indistinguishable from the distribu-
tion of the full-length CRT. Likewise, at the electron micro-
scope immunocytochemistry level the chimeras appeared
distributed throughout the ER (unpublished data).
No accumulation of either chimera was observed at the
level of the Golgi complex. We conclude that both the 67
COOH-terminal amino acid sequence residues and another
sequence (so far unidentified) contained in the rest of the
CSQ molecule are needed to induce condensation.
 
Truncation and site-directed mutants
 
To identify the specific amino acid sequences important
for CSQ condensation, we prepared a panel of expression
vectors including full-length CSQ and various NH
 
2
 
- and
COOH-terminal truncations (Fig. 2 A). L6 myoblasts and
 
HeLa cells were transfected, each with a single expression
vector, and the intracellular distribution of the expressed
protein was examined by immunocytochemistry. In all cell
types investigated, only the full-length CSQ
 
1–391
 
 (Fig. 2, B
and F) and the longest COOH terminus deletion mutant,
i.e., CSQ
 
1–350 
 
truncated by removal of 41 amino acids (Fig.
2, C and G), exhibited condensation into puncta (i.e.,
into vacuoles delimited by a single membrane). However,
a careful analysis of the puncta obtained with the two
CSQ forms revealed differences between them. In particu-
lar, in both L6 and HeLa cells transfected with full-length
CSQ
 
1–391
 
, the puncta appeared most often compact (Fig. 1 B'
and Fig. 2, B and F) and only a few exhibited an irregular hon-
eycomb or ring structure surrounding clear areas. In con-
trast, the puncta containing the truncated CSQ
 
1–350
 
 mu-
tant appeared frequently irregular, especially in L6 cells
(Fig. 2, C and G). Ultrastructural immunocytochemistry
confirmed that irregular puncta are also vacuoles contain-
ing CSQ-positive masses, though alternated to clear areas
(Fig. 2 R).
 
Figure 2.
 
Generation and expression of COOH- 
and NH
 
2
 
-terminal–truncated constructs of CSQ. 
 
(A) Graphic representation of COOH- and NH
 
2
 
-
terminal–truncated CSQ constructs with indication 
of their intracellular localization after transient 
transfection in L6 cells. The HA epitope was 
attached at the COOH terminus of only the short-
est COOH-terminal–truncated CSQ construct 
(CSQ
 
1–100
 
). (B–E
 
 
 
and F–I) Immunofluorescence of 
L6 and HeLa cells, respectively, transiently trans-
fected with the various CSQ truncation forms indi-
cated at the top. (J and K) Anti-HA immunofluores-
cence and LR White–embedded immunogold 
labeling of HeLa cells transfected with HA-CSQ
 
1–100
 
. 
(L–O)
 
 
 
Immunofluorescence with anti-HA (L and 
N) and anti-GFP (M and O) Abs in HeLa cells af-
ter cotransfection of HA-CSQ
 
1–100
 
 and GFP/CSQ 
at either high (L and M)
 
 
 
or low (N and O) ratio. 
(P and Q) Immunofluorescence with anti-HA (P) 
and anti-CSQ (Q) Abs in HeLa cells after transfec-
tion of HA-CSQ
 
1–100
 
 (the same as in N and O), 
but with CSQ
 
1–350 
 
instead of GFP/CSQ. (R) Anti-
CSQ Ab, LR White–embedded immunogold la-
beling of HeLa cell transfected with CSQ
 
1–350
 
. 
Bar (for K and R): 0.25 
 
 
 
m. 
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The distribution of the other truncation mutants diverged
substantially from that of full-length CSQ
 
1–391
 
. Whether
truncations were at the NH
 
2 
 
or at the COOH termini, when
these mutants were expressed in either L6 or HeLa cells they
all showed diffuse staining throughout the ER (Fig. 2, D, E,
and H–J), a distribution that was also confirmed by electron
microscope immunocytochemistry (Fig. 2 K and unpub-
lished data). This distribution was also seen with the trun-
cated mutant CSQ
 
1–324
 
, which corresponds to the region of
the protein included in the CSQ/CRT chimera (Fig. 2, D
and H). Therefore, we conclude that all of these truncated
CSQ forms are unable to condensate into vacuoles.
The punctate CSQ
 
1–350
 
 mutant and the diffuse CSQ
 
1–324
 
mutant differ only by the number of amino acids deleted
from the COOH-terminal region (41 and 67, respectively;
Fig. 2 A). This indicated to us that some information essen-
tial for CSQ condensation must reside in residues 325–350.
In addition, the results with NH
 
2
 
-terminal–truncated mu-
tants indicated that there was another localization in the
NH
 
2
 
-terminal region of CSQ essential for its condensation.
This conclusion was confirmed by results obtained with
the shortest COOH-terminal–truncated mutant, CSQ
 
1–100
 
,
built with an HA sequence at its COOH terminus in order
to distinguish it from the other forms used. When the HA-
CSQ
 
1–100
 
 cDNA was transfected not alone (as shown in the
legend to Fig. 2 J), but together with a hybrid protein com-
posed of the full-length CSQ
 
1–391
 
 attached at its COOH-ter-
minus to the green fluorescent protein (GFP) (GFP/CSQ),
the distribution of the two proteins varied depending on
their transfection ratio. When the truncated form predomi-
nated over GFP/CSQ (5:1), the two immunolabelings co-
distributed diffusely through the ER, with no appearance of
distinct puncta (Fig. 2, L and M); at lower ratios
 
 
 
(1:5)
puncta were evident and clearly positive, not only for GFP
but also for HA (Fig. 2, N and O). Codistribution was also
 
observed in irregular vacuoles present in the cells transfected
with HA-CSQ
 
1–100
 
 together with CSQ
 
1–350
 
 (Fig. 2, P and
Q). In contrast, when HA-CSQ
 
1–100
 
 was cotransfected to-
gether with CSQ
 
228–391
 
 (the COOH-terminal 163 amino ac-
ids, including the 324–350 sequence), the distribution of
both mutants remained diffuse (unpublished data). Taken as
a whole, these results confirm that in order to proceed, con-
densation requires the presence of full-length CSQ
 
1–391
 
 or
CSQ
 
1–350
 
 mutant molecules expressing at least two binding
sites, and that it is inhibited when the CSQ
 
1–100
 
 mutant,
which contains one site only, competes for the binding.
To identify the two binding sites at higher resolution, ex-
periments were set up in which the full-length protein was
deleted of short amino acid sequences, or point mutated at
strategically located sites. When either site A or site B was
deleted, the distribution of the mutants was diffuse (Fig. 3,
B and C), coinciding largely with that of CRT (Fig. 3, B
 
 
 
and C
 
 
 
). Largely diffuse distribution was also obtained after
site-specific mutation of full-length CSQ (Fig. 4 A) at three
acidic amino acids in site B, D341A, E344A, and D345A
(Fig. 4 C). In contrast, site-specific mutation of three, more
proximal glutamic acid residues (E337A, E338A, and
E340A) failed to affect the punctate distribution, which re-
mained unchanged with respect to intact CSQ (Fig. 4 B).
 
Cellular properties of the CSQ-filled vacuoles
 
Additional experiments were aimed at characterizing CSQ
puncta as organelles of living cells. In particular, we sought
to establish whether CSQ puncta are stable structures or un-
Figure 3. Site-specific deletions of CSQ. (A) Graphic representa-
tion of full-length CSQ showing the two binding sites, A and B, with 
the corresponding amino acid sequences. (B, C, B , and C ) L6 cells 
were cotransfected with CSQ constructs deleted of either site A (B) 
or site B (C), together with HA-CRT (B  and C ). The Abs employed 
for immunofluorescence labeling are indicated at the top of the 
panels.
Figure 4. Point mutations in the CSQ B binding site. (A) Graphic 
representation of the point mutations in two distinct, three acidic 
amino acid sets within site B. (B, B , C, and C ) L6 cells were 
cotransfected with one point-mutated construct together with HA-
CRT. The figure compares the immunofluorescence patterns in 
the cells labeled with anti-CSQ (B and C) and anti-HA (B  and C ) 
Abs, as indicated at the top of the panels. 
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dergo rapid changes in size and/or number, and whether
they tend to keep their position or move around within the
cell. To this end, L6 and HeLa cells were transiently trans-
fected with the GFP/CSQ chimera. Fig. 5, A–A
 
  
 
, illustrates
the results obtained with HeLa cells. No obvious changes in
the average number and size of puncta and of their general
pattern of distribution were evident during up to 44 h of in-
cubation. However at the level of single vacuoles, small and
slow displacements were observed especially, but not only, at
the periphery of the cell (Fig. 5, A–A
 
  
 
). Identical results
were obtained with the GFP/CSQ chimera containing the
COOH-terminal KDEL, i.e., the ER retrieval amino acid
sequence (Fig. 5 B). When the cells were treated with no-
codazol (33 nM, 1 h) in order to disassemble microtubules,
the general distribution and low mobility of puncta were not
affected (unpublished data). We conclude that CSQ vacu-
oles are long-lived, little-moving organelles. Our results ex-
clude that the vacuoles travel rapidly along microtubules, as
recently shown for cytoplasmic aggregates of denatured pro-
teins, the so-called aggresomes (Kopito and Sitia, 2000).
CSQ is a Ca
 
2
 
 
 
-binding and storage protein. Therefore, we
investigated whether changes in the ER luminal Ca
 
2
 
 
 
 
 
con-
centration have any effect on CSQ condensation within in-
tact cells. HeLa or L6 cells, transfected with the GFP/CSQ
chimera, were suspended in Ca
 
2
 
 
 
-free, 1 mM EGTA-con-
taining medium, and exposed to 1 
 
 
 
M ionomycin, a Ca
 
2
 
 
 
ionophore. Based on the results of our previous studies in
the CSQ-L6 cell model, we knew that this treatment in-
duces rapid depletion of the intracellular Ca
 
2
 
 
 
 stores, with
transfer of the cation to the extracellular medium (Gatti et
al., 1997). However, after up to 2 h incubation with the
Ca
 
2
 
 
 
 ionophore, the CSQ immunolabeling appeared unaf-
fected, as shown by the persistence of the typical cytoplasmic
puncta (Fig. 5, C–C
 
   
 
). We conclude that changes in the
ER luminal Ca
 
2
 
 
 
 concentration do not greatly affect the
condensed state of CSQ within the vacuoles.
 
ER retention of CSQ
 
To investigate whether and to what extent retention of CSQ
within the ER and ER-derived vacuoles depends on its con-
densation competence or a different mechanism(s), batches
 
of L6 and HeLa cells (some stably expressing, others not ex-
pressing the full-length CSQ) were transfected with either
one of the COOH-terminal–truncated mutants, CSQ
 
1–350
 
and CSQ
 
1–324
 
, characterized by punctate and diffuse ER
distribution, respectively. 46 h after transfection the cells
were pulse labeled with [
 
35
 
S]methionine (30 min) and then
chased for up to 5 h. Part of the results obtained in HeLa
cells can be seen in Fig. 6; similar results from L6 cells are
not shown. The labeled, stably transfected full-length CSQ
discharged to the medium was only a tiny fraction of that re-
covered within the cells. Moreover, its rate of discharge dur-
ing the first hour was 
 
 
 
1/50 of that of a typical secretory
protein, chromogranin B, transfected to parallel batches of
cells and investigated in parallel (unpublished data). The
CSQ result was expected because it is consistent with our
previous data documenting only minimal transport of the
protein to the Golgi complex and the extracellular space
(Gatti et al., 1997). The results obtained with the truncated
mutant CSQ
 
1–350
 
 documented only a slightly higher release
to the medium, which remained very low, irrespective of the
coexpression of full-length CSQ. Unexpectedly, the dif-
fusely distributed CSQ
 
1–324
 
 mutant was released at a rate
similar to full-length CSQ, i.e., not more, but even less effi-
ciently than CSQ
 
1–350 (Fig. 6). Similar results were obtained
by additional experiments carried out in parallel with
batches of unlabeled cells, in which release of full-length and
truncated CSQ forms was revealed by Western blotting of
cells and media, collected at the same time points of the
pulse–chase experiments.
Discussion
In this paper, the process of CSQ accumulation within dis-
crete domains of the ER/SR is defined as condensation. This
definition was chosen by analogy with the process taking
place at the trans-Golgi network, where condensation of
secretory proteins gives rise to immature granules (condens-
ing vacuoles). Condensation should not be confused with
aggregation, i.e., the state of denatured secretory proteins
trapped within the ER lumen because they are able to pass
neither the quality control for Golgi transport nor the trans-
Figure 5. Fluorescence labeling of living HeLa cells transfected with the GFP/CSQ chimera. (A, A , and A  ) Single field of HeLa cells trans-
fected 26 h before with the expression vector encoding the chimera GFP/CSQ. The distribution of the vacuoles rich in CSQ was followed in 
vivo by the GFP fluorescence at 0 (A), 2 (A ), and 10 min (A  ). The square delimits vacuoles that showed some movements during incuba-
tion. The same chimera, but with a KDEL signal at the COOH terminus, shows a similar pattern of distribution (B). (C, C , C  , and C   ) Single 
field of cells transfected 26 h before and then treated with the Ca
2  ionophore, ionomycin (1  M), administered in Ca
2 -free EGTA medium 
for 0, 20, 60, and 120 min, respectively.530 The Journal of Cell Biology | Volume 154, 2001
location to the cytosol through the ER membrane. These ag-
gregates are composed by proteins extensively cross-linked
by disulfide bridges. They have no physiological role but are
destined to be disposed of by autophagocytosis (Ellgaard et
al., 1999; Kopito and Sitia, 2000).
CSQ-filled vacuoles as specialized ER domains
The main task of this work was the identification of the mo-
lecular mechanisms responsible for condensation and reten-
tion of CSQ within the ER and ER-derived organelles. In
striated muscle fibers such a retention was often attributed to
the direct binding of the CSQ acidic tail to triadins and
junctins, two families of transmembrane proteins that pro-
trude into the cisternal lumen with their long, highly basic
COOH-terminal tails (Guo and Campbell, 1995; Jones et
al., 1995; Kobayashi et al., 2000; Shin et al., 2000). How-
ever, although expression of triadins and junctins is consider-
able in muscle fibers, their levels are distinctly lower than
those of CSQ (Knudson et al., 1993; Jones et al., 1995;
Zhang et al., 2001). Therefore, a single retention/condensa-
tion mechanism based on a molecule-to-molecule binding
between CSQ and these basic proteins appears unlikely.
Moreover, in the other cells that express CSQ, the two basic
SR proteins are not expressed at all, yet CSQ does condense
within discrete vacuoles to levels comparable with those ob-
served in SR terminal cisternae (Villa et al., 1991, 1993;
Volpe et al., 1991; Papazafiri et al., 1994; Raichman et al.,
1995; Gatti et al., 1997). Most likely, therefore, the interac-
tion with triadins and junctins is not important for conden-
sation but is instrumental to a subsequent process taking
place only in muscle fibers, the docking of the condensed
CSQ matrices to the junctional face of SR terminal cisternae.
Another mechanism that has been considered to explain
condensation is dependence on the high Ca
2  concentration
typical of the ER/SR lumen (He et al., 1993). Indeed, the
triadin/junctin interaction with CSQ is released in vitro by
Ca
2  withdrawal (Shin et al., 2000). However, in intact L6
or HeLa cells transfected with CSQ, vacuoles remained ap-
parently unchanged after long treatment with the Ca
2  ion-
ophore ionomycin applied in Ca
2 -free medium, a condi-
tion known to largely deplete ER stores of their segregated
Ca
2  (Gatti et al., 1997). Thus, Ca
2  appears unnecessary
for the in vivo maintenance of CSQ in its condensed state.
From the structural point of view, the CSQ-containing
vacuoles appeared heterogeneous. In fact, some were regu-
larly spherical, dense, and compact, whereas others (espe-
cially those containing the truncated CSQ
1–350 mutant) were
irregular, with a content alternating dense and clear areas.
Content heterogeneity is not unique to CSQ-containing
vacuoles, but has been observed in the content of various
hormone secretion granules (see for example Orci, 1982),
possibly due to peculiar aspects of their condensation pro-
cesses. The ultimate significance of content heterogeneity re-
mains undefined.
Our previous studies (Gatti et al., 1997) had excluded the
CSQ-containing vacuoles to be lysosomes, endosomes, and
part of the Golgi complex. In contrast, vacuoles were identi-
fied as discrete, specialized domains of the ER, similar in a
few aspects to the SR terminal cisternae and resembling
more closely the CSQ-rich vacuoles that appear within myo-
cytes of transgenic mice overexpressing the protein (Jones et
al., 1998; Sato et al., 1998). An additional property of the
CSQ vacuoles revealed in the present work, low mobility
throughout the cytoplasm, was not due to their interaction
with microtubules, because it was unaffected by depolymer-
ization induced by nocodazol. An alternative possibility is
the direct interaction with the ER network, a system in con-
tinuous protein exchange with the vacuoles (Gatti et al.,
1997) that as a whole undergoes only slow oscillations and
retractions within the cells (Terasaki and Jaffe, 1993).
The CSQ condensation process
The molecular mechanisms of CSQ condensation were inves-
tigated in a large spectrum of mutants expressed in both L6
and HeLa cells. The first series of experiments was carried out
by using chimeras of CSQ with another ER luminal Ca
2 -
binding protein, CRT. In spite of their low degree of homol-
ogy, luminal distribution, and function (CRT is a chaperone
diffuse throughout the whole ER) (Michalak et al., 1999; Mo-
linari and Helenius, 2000), CSQ and CRT share similarities
in structure and low-affinity Ca
2 -binding properties. These
similarities are particularly evident at their highly acidic
COOH-terminal tail (70–80 amino acids), a region consid-
ered of importance also for the non-KDEL mechanism of re-
tention in the ER (Sonnichsen et al., 1994). However, in both
cell types investigated the results clearly excluded CSQ con-
densation to depend on the acidic tail alone. In fact, both the
CRT/CSQ and the CSQ/CRT chimeras remained diffusely
distributed throughout the ER lumen. These data strongly
suggest the existence of not one but at least two condensation
sites, one located in the COOH-terminal tail, the other else-
where in the CSQ molecule. The existence of an NH2-termi-
nal site was confirmed by coexpression results with the GFP/
CSQ chimera and the COOH-terminal–truncated mutant
Figure 6. Release from HeLa cells of stably transfected full-length 
CSQ
1–391 and of transiently transfected CSQ
1–350 and CSQ
1–324. Par-
allel batches of cells stably expressing CSQ
1–391 were transfected 
transiently with either one of the constructs and investigated 46 h 
later. After transfer to methionine- and serum-free medium, the cells 
were pulse-labeled with [
35S]methionine (30 min) and then chased 
for up to 180 min. The data shown (averages of two consistent ex-
periments) represent the radioactivity in the various CSQ forms re-
covered in the medium after the indicated times of incubation and 
purified by immunoprecipitation and SDS-PAGE. They are ex-
pressed as a percentage of the total radioactivity in each CSQ form 
(cells   medium).Condensation and ER storage of calsequestrin | Gatti et al. 531
CSQ
1–100. In fact, depending on their expression ratio, the
two forms were seen colocalized within either the ER cisternae
or the vacuoles, strongly suggesting their direct binding. Fi-
nally, the existence of two binding sites was confirmed by the
results with truncated and point-mutated constructs that lead
to the identification of site A, corresponding to the short
NH2-terminal 15–amino acid sequence, and site B, located
COOH-terminal of residue 337, with critical involvement of
the CSQ acidic residues 341, 344, and 345.
The CSQ condensation model
Based on the specific information reported so far, on previous
biochemical results (Cala and Jones, 1983; Maguire et al.,
1997; Zhang et al., 1997) and the known crystal structure
(Wang et al., 1998), we have developed a model for CSQ
condensation using the Biopolymer option in InsightII soft-
ware (Fig. 7). The x-ray results had revealed that the protein
may form “front-to-front” and “back-to-back” dimers (Fig.
7, F-F and B-B, respectively; Wang et al., 1998) in which the
NH2 terminus and the COOH terminus could either fit into
a groove between domains 1 and 3 or face away from the
dimer interface, thereby enabling them to interact with other
CSQ molecules. From these data, models of possible higher
oligomers were developed. Only two regularly repeating
structures showing the expected NH2- and COOH-terminal
alignment were identified. The first is the front-to front and
back-to-back oligomer revealed also by x-ray (Wang et al.,
1998), the other is a “front-to-back” structure (Fig. 7, poten-
tial) that emerged from the analysis of the present data. The
localization near the COOH terminus of the  -helical region
including the critical residues, D341, D344, and D345, far
away from the NH2-terminal sequence, appears compatible
with its direct involvement in the CSQ–CSQ intermolecular
binding. The polymers established according to the above
models most likely correspond to the CSQ filaments revealed
by electron microscopy within deep-etched SR terminal cis-
ternae (Franzini-Armstrong et al., 1987).
CSQ retention
Our pulse–chase release experiments confirmed that during
cell life, only a minimal fraction of the full-length CSQ
1–391
is released to the medium, whereas the rest is retained within
the cell (Gatti et al., 1997). If retention were a conse-
quence of condensation, it should be shown only by full-
length CSQ
1–391 and the COOH-terminal–truncated mu-
tant CSQ
1–350, and does not extend to the diffusely distributed
mutant CSQ
1–324 that lacks one of the two condensation
sites. In contrast, our results also demonstrate that the dif-
fuse CSQ
1–324 mutant is released at rates at least 50-fold
slower than those of a typical secretory protein, chromogra-
nin B, that in the cells investigated is known to travel along
the pathway most likely followed by the released fraction of
CSQ, i.e., constitutive secretion. Therefore, we conclude
that retention within the ER is a property that CSQ pos-
sesses independently of its condensation competence. In
view of the similar results obtained with the full-length and
the COOH-terminal–truncated constructs, the site(s) that
prevents CSQ transport out of the ER appears to reside not
in the COOH-terminal acidic tail but in the globular do-
mains of the protein. The role of the retention site(s) might
be important, especially for the soluble, diffusely distributed
ER/SR pool in equilibrium with the condensed matrices of
vacuoles and muscle SR terminal cisternae.
In conclusion, intraluminal retention, condensation, and
specific distribution of CSQ are shown here to be sustained by
multiple and independent mechanisms. The first mechanism
is a molecular retention step, apparently similar to the KDEL-
independent process of other luminal proteins (Sonnichsen et
al., 1994; Monnat et al., 2000). The second is condensation,
which depends on specific, molecularly identified A and B
sites. The third (in striated muscle fibers but not in the other
cells where CSQ is expressed) is the specific docking of con-
densed matrices, most likely by the membrane proteins associ-
ated to ryanodine receptors, i.e., triadins and junctins (Guo
and Campbell, 1995; Jones et al., 1995; Zhang et al., 2001).
Condensation is not an exclusive property of CSQ, but
appears to also take place with other ER proteins, single or
as mixtures, in both animal and vegetal cells (see, for exam-
ple, Titorenko and Rachubinski, 1998; Choi et al., 2000;
Chrispeels and Herman, 2000). Moreover, condensation
does occur in other intracellular compartments, for example
at the trans-Golgi network of secretory cells (Chanat and
Figure 7. Model for the CSQ oligomerization process. (A) Mol-
Script (PDB1a8y) and sphere representation of the three domains 
of CSQ: red, domain 1 (residues 12–124); green, domain 2 (resi-
dues 125–228); blue, domain 3 (residues 229–352). The residues 
326–333, which were not defined in the x-ray structure (Wang et 
al., 1998), are built manually using the Biopolymer option in 
InsightII software. (B) Representation of CSQ dimers. The NH2- 
and COOH-terminal tails are colored red and blue, respectively. 
The front-to-front dimer is shown at left, the back-to-back dimer 
at right, and the front-to-back dimer at center. (C) Regular repeat-
ing oligomers of CSQ. The oligomer shown at left is the front-to-
front and back-to-back form revealed by x-ray structure (Wang et 
al., 1998). The oligomer shown at right is the front-to-back re-
peating form. In both oligomer forms, domain 2 has the same 
regular repeating spiral orientation. In contrast, the orientation of 
domains 1 and 3 differs in the two oligomeric forms. In the x-ray 
revealed oligomer, parallel spirals composed by alternating do-
main 1 followed by domain 3 are seen. In the potential oligomer, 
spirals of domain 1 and 3 run parallel to each other.532 The Journal of Cell Biology | Volume 154, 2001
Huttner, 1991; Colomer et al., 1994). Therefore, our re-
sults on CSQ, with the first identification of at least two
specific amino acid sequences necessary for condensation to
take place, might be seminal for further studies concerning
not only proteins of the ER lumen but also proteins of other
organelles.
Materials and methods
Cell lines and antibodies
The L6 myogenic cell line (Yaffe, 1973) and HeLa cells were from the
American Type Tissue Collection. Rabbit anti–chicken CSQ (Clegg et al.,
1988) and rabbit anti–rat CRT (Perrin et al., 1991) were gifts of Drs. D.O.
Clegg (Neuroscience Research Institute, University of California, Santa Bar-
bara, CA) and H.-D. Soling (Max-Planck Institute for Biophysical Chemis-
try, Goettingen, Germany), respectively. The mAb against the HA tag (mAb
12CA5) was from Berkeley Antibody Co.; antitubulin was from Amersham
Pharmacia Biotech; the polyclonal anti-GFP was from CLONTECH Labora-
tories, Inc.; and CY2- and rhodamine-labeled goat IgGs against rabbit and
mouse IgGs were from Jackson ImmunoResearch Laboratories.
Generation of the CSQ/CRT and CRT/CSQ chimeras
pcDNA CSQ/CRT and pcDNA CRT/CSQ were generated by PCR-driven
amplification. pcDX-CRT was used as a template for CRT and the CRT tail,
and pSVL-CCS was used to amplify CSQ and the CSQ tail. For CRT NH2-
terminal sequence the following primers were used: 5 -ATCGGCTAGCAT-
GCTGCTCCC-3  and 5 -ATCGGGTACCGTTGGTGATG-3 . To create the
CRT COOH-terminal tail we used 5’-ATCGGGTACCGATGAGGCGTAC-
3  and 5 -ATCGGGGCCCCTACAGCTCGTC-3 . The nucleotide sequence
encoding the NH2-terminal part of CSQ was amplified using the following
primers: 5 -ATGGGCTAGCATGAAGAGAACAC-3  and 5 -ATCGGGTAC-
CCAGACACTG-3 . For generation of the CSQ COOH-terminal tail we
used 5 -ATCGGGTACCATGGAGATTCC-3  and 5 -ATCGGGGCCCC-
TACTCATC-3 . PCR products were cloned into pcDNA3 expression vec-
tors. All sequences were confirmed by nucleotide sequencing.
Generation of NH2- and 
COOH-terminal–truncated CSQ
The NH2 and COOH terminus deletions of CSQ were generated by PCR-
driven amplification of pSVL-CCS vector. For COOH-terminal truncation, the
5  primer for all the constructs was 5 -GGGGTACCATGAAGAGAACACAC-
CTGTTCA-3  and the 3  primers were 5 -AATTGGATCCACCCTTAAGAA-
CATACAGGC-3  (for CSQ
1–100), 5 -AATTGGATCCCAATTTCTTTGCAAC-
CCCTT-3  (for CSQ
1–188), 5 -AATTGGATCCAACAAGCAGAGGAACGTCAT-
3  (for CSQ
1–297), 5 -ATCGGGTACCCAGACACTG-3  (for CSQ
1–324), 5 -AAT-
TGGATCCCTTTCCAGAAAGCACATCCT-3  (for CSQ
1–350), and 5 -AATTG-
GATCCCTCATCATCATCATCACTGT-3  (for full-length CSQ
1–391). The PCR
products were cloned into the pcDNA3 expression vector. The CSQ signal se-
quence was inserted upstream of the NH2-terminal deletions by annealing the
two following synthetic oligodeoxynucleotides with flanking HindIII and KpnI
restriction sites: 5  CTAGCAAGCTTATGAAGAGAACACACCTGTTCATCGC-
GGGGCTCTACCTGCTGGCCTCCTGCCGGGCAGGTAC-3  and 5 -CTA-
CCCGGCAGGAGGCCAGCAGGTAGAGCCCCGCGATGAACAGGTGTGT-
TCTCTTCATAAGCTTG-3 . The 5  primers for the NH2-deletions were 5 -
GGGGTACCGAGTTTGATGGCGAGTTTGCAG-3  (for CSQ
124–391), 5 -GGG-
GTACCCCTGACAAACCTTACACAGAAG-3  (for CSQ
228–391), and 5 -AATTG-
GATCCCTCATCATCATCATCACTGT-3  (for CSQ
325–391), and the 3  primer
was the same as that used for full-length CSQ
1–391. The PCR products were
cloned in the pcDNA3 expression vector. The 3  primer was the same as that
used for full-length CSQ
1–391. The HA epitope was introduced as the following
synthetic oligodeoxynucleotides flanked by BamHI and ApaI restriction sites:
5 -GAQTCCTACCCATATGATGTTCCTGACTATGCGTAGGGC-3  and 5 -
CTACGCATAGTCAGGAACATCATATGGGTAG-3 .
Generation of CSQ mutants
Deletions or point mutations in the CSQ cDNA region were created using
the Quick-Change Mutagenesis kit (Stratagene), as recommended by the
manufacturer. 5  and 3  primers covering the NH2- and COOH-terminal
region of CSQ were generated and used for PCR-driven amplification. To
generate the site A deletion mutant (Fig. 2) we used the 5  oligodeoxynu-
cleotide 5 -TCCTGCCGGGCAGTCAGTCTCACT-3  and the 3  oligode-
oxynucleotide 5 -AGTGAGACTGAGTGCCCGGCAGGA-3 , and for the site
B deletion mutant (Fig. 2) the 5  oligodeoxynecleotide was 5 -CCCA-
CAGCTGAGAATGAAGAGGGG-3  and the 3  oligodeoxynucleotide was
5 -CCCCTCTTCATTCTCAGCTGTGGG-3 . For site-specific mutation (site
B) of E337A, E338A, and E340A, the 5  oligodeoxynucleotide was 5 -
CCTGCCCACAGCTGCGGCGCTGGCGGACTGGATCG-3  and the 3 
oligodeoxynucleotide was 5 -CGATCCAGTCCGCCAGCGCCGCAGCT-
GTGGGCAGG-3 . For site specific mutation (site B) of D341A, E344A,
and E345A, the 5  oligodeoxynucleotide was 5 -GGAGCTGGAGGCCTG-
GATCGCGGCTGTGCTTTCTG-3  and the 3  oligodeoxynucleotide was
5 -CAGAAAGCACAGCCGCGATCCAGGCCTCCAGCTCC-3 . All sequences
were confirmed by nucleotide sequencing.
Generation of GFP/CSQ chimeras
The plasmid pS65T-C1 containing cDNA encoding GFP was purchased
from CLONTECH Laboratories, Inc. To create expression plasmid encod-
ing GFP/CSQ chimera the signal sequence of CSQ was first inserted at the
5  end of GFP cDNA; this was followed by cloning CSQ cDNA at the 3 
end of GFP cDNA. CSQ cDNA was generated by PCR-driven amplifica-
tion using as 5  oligodeoxynucleotide 5 -AATTGACAGAAGAGGGGCT-
CAAC-3  and the 3  oligodeoxynucleotide 5 -TTAAGCGGCCGCCTCAT-
CATCATC-3 ; or the CSQ sequence including at its COOH-terminal a
KDEL signal using as 3  oligodeoxynucleotide 5 -TAAGAATTCATAAT-
TCATCCTTCTCATCATCATCATCATT-3 .
Cell culture, transient transfections, 
immunofluorescence, electron microscopy, and 
immunoelectron microscopy
L6 myoblast and HeLa cells were transfected as described previously (Gatti
et al., 1997). Expression vectors for HA-tagged CRT and CSQ were de-
scribed previously (Bastianutto et al., 1995; Nori et al., 1997). SDS-PAGE,
Western blot analysis, immunofluorescence, electron microscopy of Epon-
embedded sections, immunogold labeling of ultrathin cryosections, and
LR White–embedded samples were carried out as described in our previ-
ous studies (Gatti et al., 1997).
Release of CSQ and CSQ mutants to the 
incubation medium
Multiple (two per time point) monolayers of L6 and HeLa cells stably trans-
fected with full-length CSQ (Gatti et al., 1997) were transiently transfected
with either CSQ
1–350 or CSQ
1–324. 46 h after transfection the monolayers
were washed twice and covered with fresh DMEM without serum and me-
thionine, and supplemented with 140  Ci/ml of [
35S]methionine. After 30
min labeling at 37 C (pulse), monolayers were washed again and incuba-
tions were continued in a nonradioactive DMEM with serum (chase) for 0,
60, 120, 180, and 300 min. Media and detached cells were collected sep-
arately at the time points indicated above, and the various CSQ forms were
immunoprecipitated with anti-CSQ antibody (Ab). The immunoprecipi-
tates were run on SDS-PAGE gels. Additional experiments were carried out
with cell preparations stably transfected with either full-length CSQ or
CSQ
1–350. After staining (Coomassie blue) and soaking in the amplifier, the
gels were autoradiographed and the radioactivity of CSQ bands was as-
sayed by microdensitometry. Additional batches of cells, transfected with
the same CSQ forms as above, were incubated according to the same pro-
tocol, although without [
35S]methionine. At each time point, cells and me-
dia were collected and the release of full-length CSQ and mutants was es-
tablished by Western blotting.
In vivo analysis of CSQ vacuoles
Fluorescent vacuoles were generated by transient transfection of GFP/CSQ
with or without KDEL constructs. 26–44 h after transfection, washed
monolayers were covered with Krebs-Ringer medium (no serum) and trans-
ferred to the fluorescence microscope (30 C). Analyses for GFP distribution
were carried out for the times indicated in the legend to Fig. 5. In parallel
experiments, monolayers covered with Krebs-Ringer medium without Ca
2 
and containing 1 mM EGTA and 1  M of the Ca
2  ionophore, ionomycin,
were examined in the fluorescent microscope up to 120 min.
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